The Engine has returned once more to back a $30m round for Kytopen, having first invested in the MIT spinout in 2017.

Kytopen, a US-based engineered cell therapies technology spinout of Massachusetts Institute of Technology (MIT), picked up $30m in a series A round featuring Harvard University and MIT-backed incubator and venture fund The Engine.

Northpond Ventures led the oversubscribed round, which additionally attracted Horizons Ventures, Mass Ventures and Alexandria Venture Investments, a unit of life sciences real estate investment trust Alexandria Real Estate Equities, as well as private investors Michael Chambers and John Ballantyne.

Founded in 2017, Kytopen is working on…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in